Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kaprolac K70
- Development stage
- Unknown
- Lead developer
- Moberg Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Kaprolac K70 is a topical solution developed by Moberg Pharma (formerly Moberg Derma) for the treatment of distal subungual onychomycosis and nail psoriasis. The formulation is a combination of propylene glycol, urea, and lactic acid. Unlike traditional pharmacological antifungal agents, Kaprolac K70 exerts its therapeutic effect through physical and chemical mechanisms. It hydrates the nail plate, facilitates the debridement of hyperkeratotic nail tissue (keratolytic action), and acidifies the nail microenvironment to create an unfavorable condition for fungal growth. The product has been evaluated in Phase 3 clinical trials and is widely marketed globally as an over-the-counter treatment. In many jurisdictions, including the European Union, it is regulated as a medical device due to its physical mode of action.
- Brand names
- NaloxNalocEmtrixKerasal Nail
- Other names
- propylene glycol + urea + lactic acid
Beyond the preview
Go deeper on Kaprolac K70.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kaprolac K70.